Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units

NCT00167999 · clinicaltrials.gov ↗

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Gram-Positive Bacterial Infections
Escherichia Coli Infections
Klebsiella Infections

Interventions

DRUG: piperacillin-tazobactam

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer